WebMedComm - Oncology provides a home for the clinical and experimental advances on solving clinical and scientific issues of cancer, concerning all aspects of cancer research, … WebMedComm. Volume 4, Issue 2 e237. ORIGINAL ARTICLE. Open Access. Targeted therapy for cisplatin-resistant lung cancer via aptamer-guided nano-zinc carriers containing USP14 siRNA. Xinmin Zhao, Xinmin Zhao. Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Targeted therapy for cisplatin‐resistant lung cancer via …
WebApr 6, 2024 · MedComm. Volume 4, Issue 2 e247. REVIEW. Open Access. Neurological damages in COVID-19 patients: Mechanisms and preventive interventions. Sibani Sarkar, Sibani Sarkar. Division of Cancer Biology and Inflammatory Disorder, Signal Transduction in Cancer and Stem Cells Laboratory, Council of Scientific and Industrial Research-Indian … WebI’m wrapping up my third week here at BluPrint Oncology. I’ve got my blue light blocker glasses on… Donna Terrell 🌼 en LinkedIn: #jobs #medcomms #change #medcomm #oncology #hematology #teams hawk trapping techniques
华西医院又发新刊《MedComm》，已有多本属SCI期刊 - 知乎
WebJan 15, 2024 · Drugs, such as CHC, GPNA, 2DG and so on, have been designed to inhibit the important enzymes and transporters and thus to disturb metabolism in MM cells. Further details are found in the main body of text. Studies using myeloma cell lines have also shown the significance of glutamine in plasma cell metabolism. WebDec 7, 2024 · MedComm (2024). 2024 Dec; 2(4): 654–691. ... (DDR) pathways has broadened the therapeutic landscape in oncology. It is becoming increasingly clear that the genomic instability of cells resulted from deficient DNA damage response contributes to the occurrence of cancer. One the other hand, these defects could also be exploited as a … WebMedComm 是由美国最大的出版集团 Wiley 公司发行的全英文生物医学专业期刊。 主编是由英国牛津大学 James Henderson Naismith教授 （英国皇家科学院院士、英国皇家爱丁堡 … bos to st lucia